Bloomberg Businessweek
Feb 1, 2023 - 23 min
All in 1 subscription.
It sounds like science fiction, but dozens of people have undergone gene editing for cardiovascular disease and other conditions. Betsy McKay explores the pioneering use of in vivo gene editing for treating genetic diseases and the potential of this technology to transform medicine. Read by Emily Woo Zeller.